{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T18:08:03Z","timestamp":1784398083674,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003336","name":"Bulgarian National Science Fund","doi-asserted-by":"publisher","award":["DTK 02\/78"],"award-info":[{"award-number":["DTK 02\/78"]}],"id":[{"id":"10.13039\/501100003336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.intimp.2015.03.011","type":"journal-article","created":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T14:05:27Z","timestamp":1427983527000},"page":"162-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Helix pomatia hemocyanin \u2014 A novel bio-adjuvant for viral and bacterial antigens"],"prefix":"10.1016","volume":"26","author":[{"given":"Vera","family":"Gesheva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stela","family":"Chausheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Stefanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolina","family":"Mihaylova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyuba","family":"Doumanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krassimira","family":"Idakieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Tchorbanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2015.03.011_bb0005","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: current state and future trends","volume":"82","author":"Petrovsky","year":"2004","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.intimp.2015.03.011_bb0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1741-7007-8-37","article-title":"Immune mechanisms of protection: can adjuvants rise to the challenge?","volume":"8","author":"McKee","year":"2010","journal-title":"BMC Biol."},{"key":"10.1016\/j.intimp.2015.03.011_bb0015","series-title":"The Theory and Practical Application of Adjuvants","first-page":"21","article-title":"Aluminium adjuvants","author":"Lindblad","year":"1995"},{"key":"10.1016\/j.intimp.2015.03.011_bb0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4236\/wjv.2011.12007","article-title":"Selection of adjuvants for enhanced vaccine potency","volume":"1","author":"Wang","year":"2011","journal-title":"World J Vaccines"},{"key":"10.1016\/j.intimp.2015.03.011_bb0025","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1128\/JVI.68.3.1418-1425.1994","article-title":"Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implications for the pathogenesis of HBV-induced hepatitis","volume":"68","author":"Schirmbeck","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2015.03.011_bb0030","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/infdis\/174.6.1168","article-title":"MF59 adjuvant enhances the antibody response to recombinant hepatitis B surface antigen vaccine in primates","volume":"174","author":"Traquina","year":"1996","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.intimp.2015.03.011_bb0035","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/eji.1830260915","article-title":"In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to Freund's complete adjuvant, but continues to induce T helper 2 cytokine production","volume":"26","author":"Brewer","year":"1996","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2015.03.011_bb0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1586\/14760584.2.2.197","article-title":"MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile","volume":"2","author":"Podda","year":"2003","journal-title":"Expert Rev. Vaccines"},{"issue":"19","key":"10.1016\/j.intimp.2015.03.011_bb0045","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/j.vaccine.2003.11.071","article-title":"European Union regulatory developments for new vaccine adjuvants and delivery systems","volume":"22","author":"Sesardic","year":"2004","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.intimp.2015.03.011_bb0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2165\/11591760-000000000-00000","article-title":"Development of an AS04-adjuvanted HPV vaccine with the adjuvant system approach","volume":"25","author":"Garcon","year":"2011","journal-title":"BioDrugs"},{"issue":"31","key":"10.1016\/j.intimp.2015.03.011_bb0055","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1016\/j.vaccine.2011.04.053","article-title":"Comparative effects of carrier proteins on vaccine-induced immune response","volume":"29","author":"Knuf","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2015.03.011_bb0060","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0968-4328(99)00036-0","article-title":"Keyhole limpet hemocyanin (KLH): a biomedical review","volume":"30","author":"Harris","year":"1999","journal-title":"Micron"},{"key":"10.1016\/j.intimp.2015.03.011_bb0065","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1007\/BF01470992","article-title":"Marine tumor vaccine carriers: structure of the molluscan hemocyanins KLH and HtH","volume":"127","author":"Markl","year":"2001","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.intimp.2015.03.011_bb0070","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00262-004-0584-y","article-title":"Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn","volume":"54","author":"Kagan","year":"2005","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.intimp.2015.03.011_bb0075","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.juro.2006.07.136","article-title":"Immunotherapeutic effect of Concholepas hemocyanin in the murine bladder cancer model: evidence for conserved antitumor properties among hemocyanins","volume":"176","author":"Moltedo","year":"2006","journal-title":"J. Urol."},{"key":"10.1016\/j.intimp.2015.03.011_bb0080","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.fsi.2010.09.018","article-title":"Marine gastropod hemocyanins as adjuvants of non-conjugated bacterial and viral proteins","volume":"30","author":"Gesheva","year":"2011","journal-title":"Fish Shellfish Immunol."},{"key":"10.1016\/j.intimp.2015.03.011_bb0085","first-page":"159","article-title":"Copper Proteins and Copper Enzymes","volume":"vol. II","author":"Pr\u00e9aux","year":"1984"},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2015.03.011_bb0090","first-page":"109","article-title":"Components, functional units, and active sites of Helix pomatia hemocyanin","author":"Lontie","year":"1983","journal-title":"Life Chem. Rep."},{"key":"10.1016\/j.intimp.2015.03.011_bb0095","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0006-3002(61)90049-X","article-title":"Separation and absorption spectra of \u03b1-and \u03b2-haemocyanin of Helix pomatia","volume":"48","author":"Heirwegh","year":"1961","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.intimp.2015.03.011_bb0100","first-page":"455","article-title":"Gel chromatographic separation of the haemocyanins of Helix pomatia. Further electrophoretic and immunological characterization of the components","volume":"69B","author":"Gielens","year":"1981","journal-title":"Comp. Biochem. Physiol."},{"key":"10.1016\/j.intimp.2015.03.011_bb0105","first-page":"53","article-title":"Structural properties of Rapana thomasiana hemocyanin: isolation, characterization and N-terminal amino acid sequence of two different dissociation products","volume":"106B","author":"Idakieva","year":"1993","journal-title":"Comp. Biochem. Physiol."},{"key":"10.1016\/j.intimp.2015.03.011_bb0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0968-4328(00)00099-8","article-title":"Rapana thomasiana hemocyanin (RtH): dissociation and reassociation behaviour of two isoforms. RtH1 and RtH2","volume":"33","author":"Idakieva","year":"2002","journal-title":"Micron"},{"key":"10.1016\/j.intimp.2015.03.011_bb0120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0305-0491(85)90149-X","article-title":"Relative molecular mass of the polypeptide chain of \u03b2c-haemocyanin of Helix pomatia and carbohydrate composition of the functional units","volume":"82","author":"Wood","year":"1985","journal-title":"Comp. Biochem. Physiol. B"},{"key":"10.1016\/j.intimp.2015.03.011_bb0125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0076-6879(80)70046-0","article-title":"The use of carbodiimides in the preparation of immunizing conjugates","volume":"70","author":"Bauminger","year":"1980","journal-title":"Methods Enzymol."},{"issue":"15","key":"10.1016\/j.intimp.2015.03.011_bb0130","first-page":"3018","article-title":"Freund's complete and incomplete adjuvants, preparation, and quality control standards for experimental laboratory animals use","volume":"24","author":"Stewart-Tull","year":"2006","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.intimp.2015.03.011_bb0135","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.intimp.2008.03.008","article-title":"Modulation of the immune response using Rapana thomasiana hemocyanin","volume":"8","author":"Tchorbanov","year":"2008","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2015.03.011_bb0140","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2567.2007.02751.x","article-title":"Adjuvant modulation of the cytokine balance in mycobacterium tuberculosis subunit vaccines: immunity, pathology and protection","volume":"124","author":"Agger","year":"2008","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.intimp.2015.03.011_bb0145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2165\/00063030-200418020-00002","article-title":"Immunological foundations to the quest for new vaccine adjuvants","volume":"18","author":"Burdin","year":"2004","journal-title":"BioDrugs"},{"key":"10.1016\/j.intimp.2015.03.011_bb0150","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1016\/j.vaccine.2004.03.032","article-title":"Aluminium adjuvants \u2014 in retrospect and prospect","volume":"22","author":"Lindblad","year":"2004","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.intimp.2015.03.011_bb0155","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1586\/14760584.6.5.723","article-title":"GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives","volume":"6","author":"Garcon","year":"2007","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.intimp.2015.03.011_bb0160","first-page":"561","article-title":"Specific and total IgE responses to antigenic stimuli in Brown-Norway, Lewis and Sprague\u2013Dawley rats","volume":"39","author":"Abadie","year":"1980","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2015.03.011_bb0165","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.0019-2805.2004.01818.x","article-title":"Early delayed-type hypersensitivity eosinophil infiltrates depend on T helper 2 cytokines and interferon-\u03b3 via CXCR3 chemokines","volume":"111","author":"Akahira-Azuma","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2015.03.011_bb0170","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.etp.2006.03.012","article-title":"Design and evaluation of immunotoxicity studies","volume":"57","author":"Roth","year":"2006","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.intimp.2015.03.011_bb0175","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1365-2249.2004.02447.x","article-title":"Primary immune response to keyhole limpet haemocyanin following trauma in relation to low plasma glutamine","volume":"136","author":"Boelens","year":"2004","journal-title":"Clin. Exp. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915001058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915001058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T10:17:18Z","timestamp":1598869038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576915001058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1567576915001058"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2015.03.011","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Helix pomatia hemocyanin \u2014 A novel bio-adjuvant for viral and bacterial antigens","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2015.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}